Anti-Fungal Pharm Flashcards
MOA amphotericin B
forms complex with ergosterol and disrupts plasma membrane permeability (forms pores)
what organisms does amphotericin B fight against
CC(yeasts), HBC(endemic mycoses), AA(pathogenic molds) - Candida albicans • Cryptococcus neoformans • Histoplasma capsulatum • Blastomyces dermatitidis • Coccidioides immitis • Aspergillus fumigatus • Agents of mucormycosis
resistance to amphotericin B
- decreased ergosterol
- modified ergosterol (less affinity for amphotericin B)
when to give IV amphotericin B
systemic infections for wide distributions
- fungal meningitis
when to give oral amphotericin B
fungi in GI lumen
adverse effects amphotericin B
- fever, chills, muscle spasms, vom, HA, hypotension
- renal damage
- anemia
- seizures
how to prevent adverse effects amphotericin B
premedication with corticosteroids, antipyretics, antihistamines, or meperidine
MOA flucytosine
flucytosine –> cytosine permease –> FdUMP and FUTP –> FdUMP inhibits DNA synthesis, FUTP inhibits RNA synthesis
what organisms does flucytosine fight against
- C. neoformans
- some candida
- dematiaceous molds that cause chromoblastomycosis
resistance to flucytosine
altered metabolism of flucytosine
how is flucytosine administered
oral only (in US) - widely distributes in body including CNS
adverse effects flucytosine
- bone marrow toxicity (anemia, leukopenia, thombocytopenia)
- derangement of liver enzymes
MOA of azoles
reduction of ergosterol synthesis by inhibiting fungal CYP450
what organisms do azoles fight against
broad spectrum
- many candida
- c. neoformans
- endemic mycoses
- dermatophytes
- aspergillus
resistance to azoles
upregulation of fungal CYP350